✦ LIBER ✦

Erlotinib in non-small-cell lung cancer

✍ Scribed by Gridelli, Cesare; Rossi, Antonio; Maione, Paolo; Colantuoni, Giuseppe; Gaizo, Filomena Del; Ferrara, Carmine; Nicolella, Dario; Guerriero, Ciro

Book ID: 120213418
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 208 KB
Volume: 8
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656566.8.15.2579

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib in non-small cell lung cancer

📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 104 KB

Reviewing the safety of erlotinib in non

Reviewing the safety of erlotinib in non-small cell lung cancer

✍ Reck, Martin; Mok, Tony; Wolf, Jürgen; Heigener, David; Wu, Yi-long 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 383 KB

Alveolar hemorrhage due to erlotinib in

Alveolar hemorrhage due to erlotinib in non-small-cell lung cancer resistant to gefitinib

✍ Yano Shuichi 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 262 KB

Response to gefitinib and erlotinib in N

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

✍ Ivette F Emery; Chiara Battelli; Paul L Auclair; Kathleen Carrier; Daniel M Haye 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 574 KB

9133 Analysis of treatment effects of er

9133 Analysis of treatment effects of erlotinib in non small cell lung cancer patients

✍ Babicková, L.; Tomíková, M.; Skricková, J.; Kaldec, B.; Kaplanová, J.; Pavlí, T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A Benefit-Risk Assessment of Erlotinib i

A Benefit-Risk Assessment of Erlotinib in Non-Small-Cell Lung Cancer and Pancreatic Cancer

✍ Giannis Mountzios, Kostas N. Syrigos 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 141 KB